dough - Do you have any idea why Ariad has not yet initiated plans to study the abilty of AP26113 to pass the blood brain barrier? They said they might add an arm to the phase 2 or do a separate study but did not really expound on the subject at the CC.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.